We infused Wnt5a and Wnt11 into sham or TAC mice for 2 weeks, and observed serum Wnt5a or Wnt11 level was significantly increased at 4 weeks after sham or TAC operation compared with their control group, respectively (Fig. 3D). The gene discussed is WNT11; the disease is persistent truncus arteriosus.